書籍詳細

I. アレルギー性皮膚疾患

P.23 掲載の参考文献

• 1) 高森建二, 内藤勝一, 小川秀興 : 自己免疫性水疱症のプロテアーゼインヒビターによる治療. Medical Immunology, 14 : 379, 1987.

• 2) Schiltz, J.R, et al. : Production of epidermal acantholysis in normal human skin in vit ro by the IgG fraction from pemphigus serum. J. Invest. Dermatol., 67 : 254, 1976.

• 3) Morioka, S., et al. : The pathologic role of pemphigus antibodies and proteinase in epidermal acantholysis. J. Invest. Dermatol., 76 : 337, 1981.
  pubmed

• 4) Hashimoto, K., et al. : Anti-cell surface pemphigus autoantibody stimulates plasminogen activator of human epidermal cells. A mecha-nism for the loss of epidermal cohesion and blister formation. J.Exp.Med., 157 : 259, 1983.

• 5) Stanley, J.R., et al. : Pemphigus vulgaris and pemphigus foliaceus autoantibodies bind different molecules. J. Invest. Dermatol., 82 : 439, 1984.

• 6) Naito, K., et al. : Experimental bullous pemphigoid in guinea pigs : The role of pemphigoid antibodies, complement and migfating cells. J. Invest. Dermatol., 82 : 227, 1984.

• 7) Mutasim, D.F, et al. : Apool of bullous pemphigoid antigen is intracellular and associated with the basal cell cytoskeleton hemidesmosome complex. J. Invest. Dermatol., 84 : 47, 1985.

• 8) Stanley, J.R., et al. : Characterization of bullous pemphigoid antigen : A unique basement membrane protein of stratified squamous epithelia. Cell, 24 : 897, 1981.
  pubmed

• 9) Fine, J.D. : The skin basement membrane zone ; in Advances in Dermatology. Vol.2 : pp.283-303, Year Book Med. Publ. Inc. Chicago, London, 1987.

• 10) Holmes, R.C.&Black, M.M. : The fetal prognosis in pemphigoid gestationis(herpes gestationis). Brit. J. DermatoL, 110 : 67, 1984.

• 11) 矢尾板英夫 : 疱疹状皮膚炎. "皮膚免疫組織アトラス"(植木宏明, 矢尾板英夫 編) p.76, 南江堂, 東京, 1986.

• 12) 山崎雄一郎, 他 : Linear IgA bullous dermatosis. 疱疹状皮膚炎. "皮膚免疫組織アトラス"(植木宏明, 矢尾板英夫 編), p.74.

• 13) Huff, J.C., et al. : Intraepidermal neutrophilic IgA dermatosis. N.Engl. J. Med., 313 : 1643, 1985.
  pubmed

• 14) Wallach, D. : Intraepidermal neutrophilic IgA dermatosis. N. Engl. J. Med., 315 : 66, 1986.
  pubmed

• 15) Tagami, H., et al. : Subcorneal pustular dermatosis with vesicle-bullous eruption. Brit. J. Dermatol., 109 : 581, 1983.

• 16) Hashimoto, T., et al. : Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis, Arch. Dermatol., 123 : 1062, 1987.
  pubmed

• 17) Yaoita, H., et al. : Epidermolysis bullosa acquisita : Ultrastructual and immunological studies. J. Invest. Dermatol., 76 : 288, 1981.

• 18) 古江増隆 : 後天性表皮水疱症. "皮膚免疫組織アトラス"(植木宏明, 矢尾板英夫 編) p.72, 南江堂, 東京, 1986.

• 19) Yoshiike, T., et al. : Epidermolysis bullosa acquisita antigen : Relationship between the collagenase-sensitive and insensitive do-mains. J. Invest. Dermatol., 90 : 127, 1988.

• 20) Yung, C. W.& Hambrick, G. W. : D-penicillamine-induced pemphigus syndrome. J. Am. Acad. Dermatol., 6 : 317, 1982.
  pubmed

• 21) 大田知子, 他 : Dペニシラミン服用中の原発性胆汁性肝硬変患者に生じた天庖瘡様皮膚病変. 西日皮膚, 47 : 1026, 1985.

• 22) Ruocco, V., et al. : In vitro acantholysis by captopril and thiopronine. Dermatologica, 176 : 115, 1988.
  pubmed

• 23) 植木宏明 : 概念とその変遷. 皮膚科Mook 7 "エリテマトーデスの臨床"(今村貞夫, 小川秀興 編) p.1, 金原出版, 東京, 1986.

• 24) 坂根剛 : 細胞性免疫所見とその読み方. 皮膚科Mook 7 "エリテマトーデスの臨床 "(今村貞夫,小川秀興 編), p.47.

• 25) Gilliam, J.N. & Sontheimer, R. D. : Distinct cutaneous subsets in the spectrum of lupus erythematosus. J. Am. AcadDermatol., 4 : 471, 1981.
  pubmed

• 26) Hood, A. F. : Pathology of cutaneous lupus erythematosus ; in Advances in Dermatology(by Callen et al.), Vol.2 : pp.153-170, Year Book Med. Publ. Inc. Chicago, London, 1987.

• 27) 宮川幸子, 他 : 新生児エリテマトーデス. 皮膚臨床, 28 : 239, 1986.

• 28) Nitsche, J. F, et al. : Rocket immunoelectrophoresis of C 4 and C 4 d. A simple sensitive method for detecting complement activation in plasma. Am. J. Clin. Pathol., 76 : 679, 1981.

• 29) Milgrom, H., et al. : Activation of the forth component of comple-ment(C 4) : Assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4. J. Immunol., 124 : 2780, 1980.

• 30) 竹村周平, 他 : 補体について, 日本臨床免疫学会会誌, 11 : 92, 1988.

• 31) 鈴木秀二 : EBウイルスと免疫不全. 臨床免疫, 19 : 480, 1987.

• 32) Iida, K., et al. : Complement receptor(CRI)deficiency in erythrocytes from patients with SLE. J. Exp. Med., 155 : 1427, 1982.

• 33) Djeu, J. Y. : Decreased IL2 inhibitor in sera of patients with autoimmune disorders. Clin. Exp. Immunol., 65 : 279, 1986.
  pubmed

• 34) Volk, H.D. : IL2 normalizes defective suppressor T cell function of patients with SLE in vitro. Clin. Exp. Immunol., 66 : 525, 1986.
  pubmed

• 35) Linker-Israeli, M, et al. : Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus. J. Immunol., 130 : 2651, 1983.
  pubmed

• 36) Sano, H. : SLE sera anti-lymphocyte reactivity : Detection of antibodies to Tac antigen positive cell lines. Clin. Exp. Immunol., 63 : 8, 1986.
  pubmed

• 37) Kohchiyama, A., et al. : Tcell subsets in lesions of SLE and DLE. J. Cutan. Pathol., 12 : 493, 1985.
  pubmed

• 38) Ueki, H., et al. : Immun-Komplexe in der Dermatologie heute. Hautarzt, 34 : 371, 1983.

• 39) 小川まゆみ, 斎田洋子 : エリテマトーデスの皮疹部のs-proteinの局在. 日皮会誌, 98 : 1988. (印刷中)

• 40) Hiorigome,I., et al. : Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases. Clin. Exp. Immunol, 0 : 417, 1987.

• 41) Norris, D. A., et al. : The role of RNP, Sm and SS-A/Ro-specific antisera from patients with lupus erythematosus in inducing antibody-dependent cellular cytotoxicity(ADCC)of targets coated with nonhistone nuclear antigens. Clin. Immunol. Immunopathol., 31 : 311, 1984.

• 42) Lieu, T.-S., et al. : Immunoglobulin class and subclass profile of the RO/SS-A autoantibody response. J. Invest. Dermatol., 90 : 158, 1988.

• 43) Furukawa, F., et al. : Estradiol enhances binding to cultured keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. J. Immunol., 1988(in press).

• 44) Furukawa, F., et al. : Ultraviolet light induction of Ro and La antigen on human keratinocytes : A crucial component of photosensitive cutaneous lupus erythematosus? Clinical Res., 36 : 249 A, 1988.

• 45) 植木宏明, 稲垣安紀, 他 : 細胞質および核内小分子量RNP抗原解析の試み(特にSS-A/RoおよびSS-B/La抗原を中心として). 厚生省特定疾患 "強皮症" 調査研究班昭和61年度研究報告書, P.170, 昭和62年3月.

• 46) Izui, S., et al. : Association of circulating retroviral gp 70-anti-gp 70 immune complexes with murine systemic lupus erythematosus. J. Exp. Med., 149 : 1099, 1979.
  pubmed

• 47) Husby, G., et al. : Tissue c-myc protein expression and immune response in systemic lupus erythematosus. Clin. Exp. Immunol., 69 : 493, 1987.

• 48) Boumpas, D. T., et al. : Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis&Rheum. 29 : 755, 1986.
  pubmed

• 49) Rodnan, G. P, and Jablonska, S. : Classification of systemic and localized scleroderma ; in Current Topics in Rheumatology(ARA)-Systemic Sclerosis, by Black C. M & Myers, A. R. p.3. Gower Medical Publ. Limited. New York, 1985.

• 50) 石川英一 : 過去6年間(昭和56-61年)の調査研究の総括. 厚生省特定疾患 "強皮症" 調査研究班昭和61年度研究報告書, p.1, 昭和62年3月.

• 51) Nishioka, K., et al. : Mast cell numbers in diffuse scleroderma. Arch. Dermatol., 123 : 205, 1987.
  pubmed

• 52) Hatamochi, A., et al. : Effect of histamine on collagen synthesis by cultured fibroblasts derived from guinea-pig skin. Arch. Dermatol. Res., 277 : 60, 1985.
  pubmed

• 53) 臼井俊和, 他 : 皮疹を主訴としたSjogren症候群. 日皮会誌, 92 : 489, 1982.

• 54) Friedman, H.M., et al. : Glycoprotein C of herpes simplex virus 1 acts as a receptor for C3b of infected cells. Nature,309 : 633, 1984.
  pubmed

• 55) Yoshiki, T., et al. : The structural proteins of murine leukemia virus and the pathogenesis of necrotizing arteritis and glomerulonephritis in SL/NI mice. J. ImmunoL, 122 : 1812, 1979.

• 56) Van Hale, HM., et al. : Henoch-Schonlein vasculitis : Direct immun-ofluorescence study of uninvolved skin. J. Am. Acad. Dermatol., 15 : 665, 1986.

• 57) Sanches, N.P., et al. : The clinical and histological spectrums of urticarial vasculitis. J. Am. Acad. Dermatol., 7 : 599, 1982.

• 58) Imamura, S., et al. : Erythema multiforme. Brit. J. Dermatol., 102 : 161, 1980.

• 59) Guilhou, J. J., et al. : Immunological aspects of psoriasis. Brit. J.. Dermatol., 102 : 173, 1980.

• 60) James, WD., et al. : Graft-vs-Host disease. Arch. Dermatol., 119 : 683, 1983.
  pubmed

• 61) Saurat, J.H., et al. : The lichen planus-like eruption after bone marrow transplantation. Brit. J. DermatoL, 92 : 675, 1975.

• 62) 今井龍介, 三浦淳子, 他 : 円形脱毛症の病態に関する研究. 日皮会誌, 98 : 355, 1988.

P.49 掲載の参考文献

• 1) Coombs, R. R. A., Gell, P. G. H. : Classification of allergic reactions responsible for clinical hypersensitivity and disease. in Clinical Aspects of lmmunology, 3rd ed. p761, Blackwell Scientific Publications Ltd., Oxford, 1975.

• 2) Prausnitz, C., Kustner, H. : Studien uber die Uberampfindlichkeit. Zbl. Bakt., 86 : 160, 1921.

• 3) Ishizaka, K. et al. : Physicochemical properties of reaginic antibody. IV. Presence of unique immunoglobulin as a carrier of reaginic activity. J. Immunol, 97 : 75, 1966.

• 4) Ishizaka, K. et al. : Physicochemical properties of reaginic antibody. V.Correlation of reaginic activity with E-globulin antibody. J. Immounol,, 97 : 840, 1966.

• 5) Ishizaka, K., Ishizaka, T. : Identification of E-antibodies as a carrier of reaginic activity. J. Immunol., 99 : 1187, 1967.
  pubmed

• 6) Ishizaka, K., Ishizaka, T. : Human reaginic antibodies and immuno-globulin-E. J. Allergy, 42 : 330, 1968.

• 7) Seldin, D. C., Austen, K. F. : Mast cell heterogeneity-the T-cell factor-dependent mast cell in vitro and in vivo. in The Urticaria, ed. by R. H. Champion et al, p12, Churchill Livingstone, Edinburgh, London, Melbourne, New York, 1985.

• 8) Ishizaka, T. : Analysis of triggering events in mast cells for immunog-lobulin E-mediated histamine release. J. Allergy Clin. Immunol., 67 : 90, 1981.

• 9) Benyon, R. C. et al. : IgE-Dependent activation of mast cells is not associated with enhanced phospholipid methylation. Biochem. Pharmacol, 35 : 2535, 1986.

• 10) Greaves, M. W. et al. : IgE-mediated hypersensitivity in human skin studied using a new in vitro method. Immunology, 23 : 239, 1972.
  pubmed

• 11) Yamamoto, S., Greaves, M. W. : Diisopropylfluorophosphate-evoked inhibition of anaphylactic histamine release from human skin : Decrease of the inhibition by storing the skin specimens. Acta Dermatovener., 59 : 121, 1979.

• 12) Yamamoto, S., Greaves, M. W. : The role of calcium in human cutaneous anaphylaxis, Int. Arch. Allergy Appl. Immunol., 44 : 797, 1973.
  pubmed

• 13) Yamamoto, S. et al. : Cyclic AMP-induced inhibition of IgE-mediated hypersensitivity in human skin. Immunology, 24 : 77, 1973.
  pubmed

• 14) Yamamoto, S. et al. : Inhibition of human cutaneous anaphylaxis by cytochalasin B. Immunology, 24 : 1007, 1973.
  pubmed

• 15) Yamamoto, S. et al. : Human skin anaphylaxis. Effect of cyclic AMP on the two stages of allergic histamine release from human skin, and colchicine-induced inhibition of cutaneous allergic histamine release. Hiroshima J. Med. Sci., 26 : 167, 1977.
  pubmed

• 16) Gillespie, E., Lichtenstein, LM. : Histamine release from human leukocytes : Studies with deuterium oxide, colchicine, and cytochal-asin B. J. Clin. Invest. 51 : 2941, 1972,

• 17) Majno, G., Palade, G. E. : Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability : an electron microscopic study. J. Biophys. Biochem. Cytol., 11 : 571, 1961.
  pubmed

• 18) Rowley, D. A. : Venous constriction as the cause of increased permeability by 5-hydroxytryptamine, histamine, bradykinin and 48/80 in the rat, Brit. J. Exp. Pathol., 45 : 56, 1964.

• 19) Majno, G. et al. : On the mechanism of vascular leakage caused by histamine-type mediators. A microscopic study in vivo. Cir. Res., 21 : 833, 1967.

• 20) Imayama, S., Urabe, H. : Pericytes on the dermal microvasculature of the rat skin. Anat. Embryol., 169 : 271, 1984.
  pubmed

• 21) Becker, C. G., Murphy, G. E. : Demonstration of contractile protein in endothelium and cells of the heart valves, endocardium, intima, arteriosclerotic plaques, and Aschoff bodies of rheumatic heart disease. Amer. J. Pathol., 55 : 1, 1969.

• 22) Majno, G. et al. : Endothelial contraction induced by histamine-type mediators A electron microscopic study. J.Cell Biol., 42 : 647, 1969.
  pubmed

• 23) 山本昇壮, 他 : 抗ヒスタミン剤. 日皮会誌, 95 : 1290, 1985.

• 24) Hide, M et al. : Histamine H1-receptor in endothelial smooth muscle cells of guinea-pig aorta. Eur. J. Pharmacol., 148 : 161, 1988.
  pubmed

• 25) Greaves, M. et al. : Receptors for histamine in human skin blood vessels : Areview. Br. J. Dermatol., 97 : 225, 1977.

• 26) 田坂賢二 : 抗ヒスタミン薬の作用機序と薬理. 薬局, 34 : 27, 1983.

• 27) Marks, R., Greaves, M. W. : Vascular reactions to histamine and compound 48/80 in human skin : Suppression by histamine H2-receptor blocking agent. Br. J CIin, Pharmacol., 4 : 367, 1977.

• 28) Juan, H, Sametz, W. : Histamine-induced release of arachidonic acid and of prostaglandins in peripheral vascular bed. Arch. Pharm., 314 : 183, 1980.

• 29) Greaves, M. W. : Mast cells, histamine and histamine release. in The Urticaria. ed.by R.H.Champion, p 3, Churchill Livingstone, Edinburgh, London, Melbourne, New York, 1985.

• 30) Hahn. F. et al. : Histaminase (diamine oxidase) in disappearance of plasma histamine in anaphylaxis and after histamine injection. Int. Arch. Allergy, 39 : 449, 1970.
  pubmed

• 31) Wasserman, S.I. : Mediators of immediate hypersensitivity.J.Allergy Clin. Immunol., 72 : 101, 1983.
  pubmed

• 32) 鹿取信 : ロイコトリエン. プロスタグランディンの新しい展開. p52, 現代医療社, 東京, 1984.

• 33) Kozuka, T. et al. : Prostaglandin D2 release by guinea pig skin during in vitro anaphylaxis induced by antigen and compound 48/80. J. Invest. Dermatol., 88 : 115, 1987.
  pubmed

• 34) 沼田恒実, 他 : I型アレルギー反応におけるヒト皮膚からのプロスタグランディンD2の遊離, アレルギー, 34 : 629, 1985.

• 35) Lewis R. A. et. al. : Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol., 129 : 1627, 1982.

• 36) Heavey, D. J. et al. : Prostaglandin D2 and histamine release in cold urticaria J. Allergy Clin. Immunol., 78 : 458, 1986.
  pubmed

• 37) Koro, O. et al. : Release of prostaglandin D2 and histamine in a case of localized heat urticaria. Br. J. Dermatol., 115 : 721, 1986.

• 38) 高路修, 他 : ヒト皮膚I型アレルギー反応におけるprostaglandin D2(PGD2)の遊離. 第12回日本研究皮膚科学会, 札幌, 1987.

• 39) Soter, N. A. et al. : Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin. J. Invest. DermatoL, 80 : 115, 1983.
  pubmed

• 40) Flower, R. J. et al. : Inflammatory effects of prostaglandin D2 in rat and human skin. Br. J. Pharmacol., 56 : 229, 1976.
  pubmed

• 41) Samuelsson, B. : Leukotrienes : mediators of immediate hyperse-nsitivity reactions and innammation. Science, 220 : 568, 1983.

• 42) 山本昇壮 : 蕁麻疹. Med. Immunol., 11 : 225, 1986.

• 43) 森田栄伸, 他 : アトピー性皮膚炎におけるI型アレルギー反応の関与の検討. 日皮会誌, 96 : 1526, 1986.

• 44) Goetzl, E. J., Austen, K. F. : Purification and synthesis of eosinop-hilotactic tetrapeptides of human lung tissue : Identification as the eosinophil chemotactic factor of anaphylaxis. Proc. Natl. Acad. Sci. USA, 72 : 4123, 1975.

• 45) Wasserman, S.I. et al. : Cold urticaria : recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J. Clin. Invest., 60 : 189, 1977.
  pubmed

• 46) Ford-Hutchinson, A. W. et al. : Leukotriene B4, a potent chemo-kinetic and aggregating substance released from polymorphonuclear leucocytes. Nature, 286 : 264, 1980.

• 47) Talbot, S. F. et al. : Accumulation of leukotriene C4 and histamine in human allergic skin reactions. J. Clin. Invest., 76 : 650, 1985.
  pubmed

• 48) Benveniste, J. et al. : Leucocyte dependent histamine release from rabbit platelets : The role of IgE, basophils and a platelet activating factor. J. Ext. Med., 136 : 1356, 1972.

• 49) Tence, M. et al. : Release, purification and characterization of platelet activating factor(PAF). Biochemie, 62 : 251, 1980.

• 50) Pinckard, R. N. : Platelet-activating factor. Hosp. Pract., 18 : 67, 1983.
  pubmed

• 51) Archer, C. B. et al. : Inflammatory characteristics of platelet activating factor(PAF-acether)in human skin. Br. J. Dermatol., 110 : 45, 1984.
  pubmed

• 52) Archer, C. B. et al. : Accumulation of inflammatory cells in response to intra-cutaneous platelet activating factor(PAF-acether)in man. Br. J. DermatoL, 112 : 285, 1985.

• 53) Grandel, K. E. et al. : Association of platelet-activating factor with primary acquired cold urticaria. New Engl. J. Med., 313 : 405, 1985.
  pubmed

• 54) Monroe, E. W. : Urticaria. Int. J.Dermatol., 20 : 32, 1981.
  pubmed

• 55) Bruynzeel-Koomen, C. et al. : The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch. Dermatol. Res., 278 : 199, 1986.
  pubmed

• 56) Warin, R. P., Champion, R. H. : Urticaria. W.B. Saunders, London, p26, 1974.

• 57) Numata, T. et al. : The role of mite allergen in chronic urticaria. Ann. Allergy, 43 : 356, 1979.
  pubmed

• 58) 山本昇壮 : 皮膚アナフィラキシー反応におけるchemical mediatorsの遊離機序およびその反応のmodulating factors. 西日皮膚. 43 : 390, 1981.

• 59) Yamamoto, S. et al., The significance of cell-bound antigen-specific IgE in chronic urticaria. Ann. Allergy, 46 : 89, 1981.
  pubmed

• 60) Ruzicka, T. et al. : Skin levels of arachidonic acid-derived inflamma-tory midiators and histamine in atopic dermatitis and psoriasis. J. Invest. Dermatol., 86 : 105, 1986.

• 61) Camp, R. et al. : Production of intraepidermal microabscesses by topical apPlication of leukotriene B4. J. Invest. Dermatol., 82 : 202, 1984.
  pubmed

P.71 掲載の参考文献

• 1) Roitt, I, : Essential Immunology,6th Ed., Blackwell Sci. Publ., 1988.

• 2) Nishioka, K. : Allergic contact dermatitis. Int. J. Dermatol. 24 : 1-8, 1985.
  pubmed

• 3) Cohen, I. R, Livnat, S. : The cell-mediated immune response : Interactions of initiator and recruited T lymphocytes. Transplant. Rev.29 : 26-58, 1976.

• 4) Asherson, G.L, Zembala, M., Mayhew, B. : Analysis of the induction phase of contact sensitivity by footpad transfer of regional lymphnode cells. Macrophages and radioresistant T lymphocyte induce immunity. Immunnology 32 : 81-88, 1977.

• 5) Moorhead, J.W. : Tolerance and contact sensitivity to DNFB in mice. VIII. Identification of distinct T cell subpopulations that mediate in vivo and in vitro manifestations of delayed hypersensitivity. J. Immunol. 120 : 137-144, 1978.
  pubmed

• 6) Stingl, G., Wolff, K. : The Langerhans cell. in Update : Dermatology in General Medicine, ed. by A.Z. Eisen, K. Wolff,I.M. Freedberg and KF. Austen, Mc Graw. Hill Book Co., 1983.

• 7) Tschachler, E, Schler, G., Hutterer, J., Leibl, H., Wolff, K., Stingl, G. : Expression of Thy-1 antigen by murine epidermal cells. J. invest. Dermatol. 81 : 282-285, 1983.

• 8) Nishioka, K., Funai, T., Yokozeki, H., Katayama,I. : Induction of hapten-specific lymphoid cell proliferation dy liposome-carrying molecules from haptenated epidermal cell in contact sensitivity. J. invest. Dermatol. 83 : 96-100, 1984.

• 9) Luger, T.A., Stadler, B.M., Katz, S.I., OPPenheim, JJ. : Epidermal cell (keratinocyte)-derived thymocyte-activating factor(ETAF). J. Immunol. 127 : 1493-1498, 1981.
  pubmed

• 10) Mizel, S.B. : Interleukin 1 and T cell activation. Immunol. Rev.63 : 51-72, 1982.

II. 皮膚科領域でのアレルギー試験とその進め方

P.90 掲載の参考文献

• 1) 田中正和, 他 : アレルギー, 36 : 672, 1987.

• 2) Fisher, A.A. : Contact Dermatitis, 3rd ed. Lea & Febiger, Philadelphia, p9, 1986.

• 3) 生野麻美子, 他 : 皮膚臨床, 28 : 423, 1986.

• 4) 富田有祐, 他 : 小児科Mook No.41, 金原出版, 東京, p91, 1986.

• 5) Ikezawa, Z., et al. : Models in Dermatology IV(ed. by Maibach, H.I. and Lowe, N. J.), Karger Publisher, Basel, in press, 1988.

• 6) Ikezawa, Z., et al. : J. Dermatol., 12 : 295, 1985.
  pubmed

• 7) 野間剛, 他 : 臨床免疫, 19〔suppl.12〕 : 170, 1987.

• 8) 相原道子, 他 : 横浜医学, 39(4) : 213, 1988.

III. アレルギーの病態と抗アレルギー薬の知識

P.112 掲載の参考文献

• 1) Roitt,I., Brostoff, J. and Male, D. : Immunology(免疫学イラストレイテッド, 多田富雄監訳, 南江堂, p.223, 1986)

• 2) 江田昭英, 稲垣直樹 : 抗アレルギー薬. 臨床免疫, 17(Suppl.9) : 228-238, 1985

• 3) 大橋裕二, 本島新司 : 化学伝達物質遊離抑制薬の種類と作用機序. アレルギーの臨床, 8(4) : 16-22, 1988

• 4) 黒沢元博 : 新しい抗喘息薬とその使い方. アレルギーの臨床, 7(11) : 27-30, 1987

• 5) 田坂賢二 : 抗アレルギー薬. 臨床免疫, 17(Suppl.9) : 239-251, 1985

IV. 皮膚科領域における抗アレルギー薬の適切な使い方

P.127 掲載の参考文献

• 1) 黒沢元博, 小林節雄 : 抗アレルギー薬. Prog. Med., 5 : 1155-1162, 1985.
  Medical*Online

• 2) 田坂賢二 : 肥満細胞からのヒスタミン遊離におけるCaイオンの関与. MEDICO, 18 : 1-10, 1987.

• 3) Altounyan, R.E.C. : Inhibition of experimental asthma by a new compound-disodium cromoglycate "Intal". Acta Allergol., 22 : 487, 1967.

• 4) 中川武正 : 抗アレルギー剤. アレルギー性疾患-予防と治療-(宮本昭正, 中川武正編), 医歯薬出版(東京), pp86-90, 1985

• 5) Freier, S., Berger, H. : Disodium cromoglycate in gastrointestinal protein intolerance. Lancet, 1 : 914-915, 1973.

• 6) Dannaeus, A., Inganas, M., Johansson, S.G.O., Foucard, T : Intestinal uptake of ovalbumin in malabsorption and food allergy in relation to serum IgG antibody and orally administered disodium cromoglycate. Clin. Allergy, 9 : 263-270, 19979.

• 7) Koda, A., Nagai, H., Watanabe, S., Yanagihara, Y., Sakamoto, K. : Inhibition of hypersensitivity reactions by a new drug, N(3', 4'-dimethoxycinnamoyl) anthranilic acid(N-5'). J. Allergy Clin. Immunol., 57 : 396-407, 1976.
  pubmed

• 8) 冨岡玖夫 : アレルギー反応のカルシウム拮抗薬による制御. MEDICO, 18 : 26-31, 1987.

• 9) 江田昭英 : 化学伝達物質遊離抑制薬-disodium cromoglycate(DSCG)とその類似薬-. 臨床医のための病態生理学講座 : 感染・アレルギー・免疫, 宮本昭正編, メジカルビュー社, 1986年, pp107-118.

• 10) 牛島信雄, 阿南貞雄, 吉田彦太郎 : アトピー性皮膚炎に対するN-5'の臨床効果. 診療と新薬, 19 : 3189-3193, 1982.

• 11) N-5'皮膚科研究班 : アトピー性皮膚炎におけるN-5'の臨床評価-多施設二重盲検法による検討-. 西日皮膚, 45 : 621-637, 1983.

• 12) Iwasa, Y., Iwasa, T., Matsui, K, Yoshimura, T., Tanaka, N., Miyazaki, K. : Anti-platelet action of an anti-allergic agent, N-(3', 4'-dimethoxycinnamoyl)anthranilic acid(Tranilast). Eur. J. Pharmacol., 120 : 231-234, 1986.
  pubmed

• 13) Martin, U., Romer, D. : Ketotifen, a new type of antianaphylactic agent. Allergol. Immunopathol, (Suppl)5 : 5-, 1977.

• 14) 宮里稔, 津田眞五, 笠田守, 井料香代子, 笹井陽一郎 : アトピー性皮膚炎患者の好酸球比重に及ぼすKetotifenの影響. 感染・炎症・免疫, 8 : 260-262, 1988.

• 15) Podleski, W.K., Panaszek, B.A. Schmidt, J.L., Burns, R.B. : Inhibition of eosinophils degranulation by Ketotifen in a patient with milk allergy, manifested as bronchial asthma-an electron microscopic study. Agents Actions, 15 : 177-181, 1984.

• 16) Tasaka, K., Mio, M., Okamoto, M. : Changes in intracellular Ca2+ distribution of rat peritoneal mast cells before and after histamine release. Agents Actions, 18 : 61-64, 1986.
  pubmed

• 17) Ketotifen皮膚科研究班 : アトピー性皮膚炎に対する抗アレルギー剤Ketotifenシロップ剤の臨床評価-多施設二重盲検群間比較試験によるClemastine Fumarateとの比較-. 西日皮膚, 48 : 534-552, 1986.

• 18) Ketotifen皮膚科研究班 : 慢性蕁麻疹に対する抗アレルギー剤Ketotifenの臨床評価-多施設二重盲検群間比較試験によるClemastine Fumarateとの比較-. 西日皮膚, 48 : 333-343, 1986.

• 19) Tasaka, K., Akagi, M., Mio, M., Miyoshi, K., Nakaya, N. : Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells. Int. Arch. Allergy appl. Immunol., 83 : 348-353, 1987.
  pubmed

• 20) Ohmori, K., Ishii, H., Kubota, T., Shuto, K., Nakamizo, N. : Inhibitory effects of oxatomide on several activities of SRS-A and synthetic leukotrienes in guinea-pigs and rats. Arch. Int. Pharmacodyn. Ther., 275 : 139-150, 1985.
  pubmed

• 21) Kosaka, Y., Kawabe, H., Ishii, A. : Oxatomide inhibits in the release of broncho-constrictor arachidonic acid metabolites (iLTC 4 and PGD 2) from rat mast cells and guinea-pig lung. Agents Actions, 21 : 32-37, 1987.

• 22) Chand, N., Pillar, J. Diamantis, W., Perhach, J.L Jr, Sofia, RD. : Inhibition of calcium ionophore (A 23187)-stimulated histamine release from rat peritoneal mast cells by azelastine : Implications for its mode of action. Eur. J. Pharmacol., 96 : 227-233, 1983.
  pubmed

• 23) 赤木正明, 見雄光庸, 田坂賢二, 木庭茂治 : Azelastineのhistamine遊離抑制機序. 応用薬理, 26 : 191-198, 1983.

• 24) 片山敏, 角田創, 佐久間義範, 甲斐広文, 片山幸一 : Azelastineのロイコトリエン産生・遊離抑制作用およびロイコトリエン拮抗作用. Prog,. Med., 6 : 1173, 1986.
  Medical*Online

• 25) Thormann. J., Laurberg, G., Zachariae, H. : Oral sodium cromoglycate in chronic urticaria. Allergy 35 : 139141, 1980.

• 26) Ortolani. C., Cornelli. U., Bellani, M., Pastorello, E., Zanussi, C. : Sodium cromoglycate and provocation tests in chronic urticaria. Ann. Allergy, 48 : 50. 52, 1982.

• 27) 阿南貞雄, 神田源太, 吉田彦太郎 : アトピー性皮膚炎と食餌. 免疫と疾患, 8 : 93-98, 1984.

• 28) 牛島信雄, 吉田彦太郎, 阿南貞雄 : 食事療法. 日小皮会誌, 5 : 114-118, 1986.

• 29) 吉田彦太郎 : Atopic dermatitisの病因. 感染・炎症・免疫, 16 : 19-30, 1986

• 30) 阿南貞雄 : アトピー性皮膚炎. アレルギー診療, 10 : 379-391, 1987.

• 31) 田中洋一, 阿南貞雄, 吉田彦太郎 : ダニ抗原の経皮侵入とそれに対する生体の反応. Current Insights in Allergy, 4 : 12-15, 1988.

• 32) Shaw, R,F. : Cromolyn therapy in chronic infantile eczema. Arch. Dermatol., 111 : 1537, 1975.

• 33) Molkhou, P., Waguet, J.-C. : Food allergy and atopic dermatitis in children : Treatment with oral sodium cromoglycate. Ann. Allergy, 47 : 173-175, 1981.
  pubmed

• 34) Cavagni, G. : Atopic dermatitis due to food allergens. Practitioner, 225 : 1657-1660, 1981.
  pubmed

• 35) 北嶋征男 : 食物過敏による気管支喘息およびアトピー性皮膚炎に対する経口用Disodium Cromoglycateの効果. 診療と新薬, 22 : 1457-1473, 1985.

• 36) 三河春樹, 他 : 食物アレルギーに対するDSCG経口剤の臨床評価-Placeboを対照とした多施設二重盲検群間比較試験-. 小児臨床, 39 : 627-640, 1986.

• 37) Atherton, D. J., Soothill, J. F, Elvidge, J. : Acontrolled trial of oral cromoglycate in atopic eczema. Br. J. Demratol., 106 : 681-685, 1982.

• 38) Lindskov, R., Knudsen, L. : Oral disodium cromoglycate treatment of atopic dermatitis. Allergy, 38 : 161-165, 1983.
  pubmed

• 39) 吉田彦太郎, 久木田淳, 玉置邦彦, 原田昭太郎, 尹淑香, 青木敏之, 堀古民生, 山本昇壮, 高路修, 計盛幸子 : 食物関与のアトピー性皮膚炎に対するDisodium Cromoglycate経口剤の臨床的検討. 診療と新薬, 23 : 297-309, 1986.

• 40) 牛島信雄, 阿南貞雄, 吉田彦太郎 : N-5'(リザベン(R))のアトピー性皮膚炎に対する長期投与経験-皮疹再発抑制効果について-. 診療と新薬, 20 : 1461-1465, 1983.

• 41) 加藤泰三, 宮澤偵二, 牧野好夫, 秋葉弘, 棚橋善郎, 斉藤信也, 高橋正昭, 石橋正夫, 五十嵐稔 : アトピー性皮膚炎におけるリザベンの長期投与. 皮膚紀要, 82 : 627-630, 1987.

• 42) 山本達雄 : 老人性皮膚掻痒症に対する経口抗アレルギー剤Ketotifenの臨床的検討. 臨床医薬, 1 : 133-140, 1985.
  Medical*Online

• 43) 土井顕 : 皮膚掻痒症に対する抗アレルギー剤Ketotifenの臨床効果. 新薬と臨牀, 34 : 1058-1061.
  Medical*Online

• 44) オキサトミド臨床研究班 : 皮膚掻痒症に対するオキサトミドの臨床的検討-多施設二重盲檢試験-. 西日皮膚, 45 : 1042-1051, 1983.